The effect of norethisterone (500 mcg) and ethinyl estradiol (35 mcg) capsules on the pituitary-ovarian axis.
D000293:Adolescent; D000328:Adult; D001682:Biological Availability; D002214:Capsules; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage / Q000378:metabolism; D004958:Estradiol / Q000097:blood*; D004997:Ethinyl Estradiol / Q000008:administration & dosage*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood*; D009640:Norethindrone / Q000008:administration & dosage*; D010060:Ovulation / Q000187:drug effects; D011092:Polyethylene Glycols; D011374:Progesterone / Q000097:blood*
D002214:Capsules; D003277:Contraceptives, Oral, Combined; D011092:Polyethylene Glycols; D004997:Ethinyl Estradiol; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D009640:Norethindrone